Hydromorphone HCl Injection
May 15, 2012
Hospira has recalled one lot of hydromorphone hydrochloride 1 mg/mL in Carpujects (NDC 00409-1283-31). Carpujects are a type of pre-filled glass cartridge. A Carpuject in the lot was discovered containing a volume greater than the intended 1 mL fill volume on the label. The recalled lot number is 07547LL (exp. 7/1/2013). Hydromorphone hydrochloride is a schedule C-II opioid that can cause serious and potentially fatal adverse effects such as respiratory depression, low blood pressure, and slowed heart rate if given in too high a dose. Patients who experience adverse effects that may be related to use of this product are advised to call a healthcare professional.
The affected lot was distributed to wholesalers and to hospitals in several states (Alaska, Alabama, Arizona, California, Colorado, Connecticut, Delaware, Florida, Indiana, Louisiana, Maryland, Massachusetts, Minnesota, Missouri, Mississippi, North Carolina, New Hampshire, New Jersey, New York, Ohio, Oklahoma, Oregon, Pennsylvania, Tennessee, Texas, Utah, Washington, Wisconsin, and the District of Columbia) between September and October of 2011.
Quarantine product from the affected lot immediately and contact Stericycle by phone (888-912-7093) to arrange product return. When ordering replacement product, send the DEA 222 form to Hospira at 1635 Stone Ridge Drive, Stone Mountain, Georgia 30083.
Additional information is available at the following link:
- MedWatch Alert:
- Press Release:
May 15, 2012; University of Utah, Drug Information Service. Copyright 2012 Drug Information Service, University of Utah, Salt Lake City, UT.